Schedule 13G ownership disclosure

Aldeyra Therapeutics Inc

Security class unavailable · CUSIP: 01438T106

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,240,458
Percent of class
12.7700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-16-001112
Form type
SC 13G
Filer
Aldeyra Therapeutics, Inc.
CIK
CIK 1341235
Filed
Feb 16, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub